Formulation containing anti-inflammatory androstane derivative | Patent Publication Number 20050020549

US 20050020549 A1
Patent NumberUS 07541350 B2
Application Number10918779
Filled DateAug 13, 2004
Priority DateAug 3, 2001
Publication DateJan 27, 2005
Original AssigneeGlaxo Group Limited
Current AssigneeGlaxosmithkline Intellectual Property Development Limited
Inventor/ApplicantsIan Richard Buxton
Amyn Pyarali Sayani
Kenton Lewis Reed
Keith Biggadike
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.